APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Imaging Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Diagnostic Imaging Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025198 pages

Choose your research edition.

Industry ResearchDiagnostic Imaging Agent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Imaging Agent Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Diagnostic Imaging Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Imaging Agent Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Imaging Agent Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Diagnostic Imaging Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diagnostic Imaging Agent include GE HealthCare, Bracco Diagnostic, Guerbet, Abx Advanced Biochemical, Bayer AG, Blue Earth Diagnostics, Cardinal Health, Eli Lilly and Company and Lantheus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diagnostic Imaging Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diagnostic Imaging Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Imaging Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diagnostic Imaging Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Diagnostic Imaging Agent Segment by Company

GE HealthCare

Bracco Diagnostic

Guerbet

Abx Advanced Biochemical

Bayer AG

Blue Earth Diagnostics

Cardinal Health

Eli Lilly and Company

Lantheus

Mallinckrodt

Navidea

Yantai Dongcheng

Foshan Rui Diao Pharmaceutical

Jubilant Pharma Limited

Diagnostic Imaging Agent Segment by Type

Conjugated Imaging Agent

Metabolic Imaging Agent

Blood Flow and Blood Volume Imaging Agents

Diagnostic Imaging Agent Segment by Application

Neurological Disease

Gastrointestinal Disease

Heart Disease

Tumor

Diagnostic Imaging Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Imaging Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diagnostic Imaging Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Diagnostic Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Diagnostic Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Diagnostic Imaging Agent Industry Trends Table 2. Diagnostic Imaging Agent Industry Drivers Table 3. Diagnostic Imaging Agent Industry Opportunities and Challenges Table 4. Diagnostic Imaging Agent Industry Restraints Table 5. Global Diagnostic Imaging Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Diagnostic Imaging Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Diagnostic Imaging Agent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Diagnostic Imaging Agent Sales Market Share by Manufacturers Table 9. Global Diagnostic Imaging Agent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Diagnostic Imaging Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Diagnostic Imaging Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Diagnostic Imaging Agent Manufacturers, Product Type & Application Table 13. Global Diagnostic Imaging Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Diagnostic Imaging Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Conjugated Imaging Agent Table 17. Major Manufacturers of Metabolic Imaging Agent Table 18. Major Manufacturers of Blood Flow and Blood Volume Imaging Agents Table 19. Global Diagnostic Imaging Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Diagnostic Imaging Agent Sales by Type (2021-2026) & (K Units) Table 21. Global Diagnostic Imaging Agent Sales by Type (2027-2032) & (K Units) Table 22. Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2026) Table 23. Global Diagnostic Imaging Agent Sales Market Share by Type (2027-2032) Table 24. Global Diagnostic Imaging Agent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Diagnostic Imaging Agent Revenue by Type (2021-2026) & (K Units) Table 26. Global Diagnostic Imaging Agent Revenue by Type (2027-2032) & (K Units) Table 27. Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2026) Table 28. Global Diagnostic Imaging Agent Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Neurological Disease Table 30. Major Manufacturers of Gastrointestinal Disease Table 31. Major Manufacturers of Heart Disease Table 32. Major Manufacturers of Tumor Table 33. Global Diagnostic Imaging Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Diagnostic Imaging Agent Sales by Application (2021-2026) & (K Units) Table 35. Global Diagnostic Imaging Agent Sales by Application (2027-2032) & (K Units) Table 36. Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2026) Table 37. Global Diagnostic Imaging Agent Sales Market Share by Application (2027-2032) Table 38. Global Diagnostic Imaging Agent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Diagnostic Imaging Agent Revenue by Application (2021-2026) & (K Units) Table 40. Global Diagnostic Imaging Agent Revenue by Application (2027-2032) & (K Units) Table 41. Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2026) Table 42. Global Diagnostic Imaging Agent Revenue Market Share by Application (2027-2032) Table 43. Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Diagnostic Imaging Agent Sales by Region (2021-2026) & (K Units) Table 45. Global Diagnostic Imaging Agent Sales Market Share by Region (2021-2026) Table 46. Global Diagnostic Imaging Agent Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Diagnostic Imaging Agent Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 50. North America Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 51. Europe Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 53. Europe Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 60. Global Diagnostic Imaging Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Diagnostic Imaging Agent Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Diagnostic Imaging Agent Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Diagnostic Imaging Agent Revenue Market Share by Region (2021-2026) Table 64. Global Diagnostic Imaging Agent Revenue Market Share by Region (2027-2032) Table 65. GE HealthCare Company Information Table 66. GE HealthCare Business Overview Table 67. GE HealthCare Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. GE HealthCare Diagnostic Imaging Agent Product Portfolio Table 69. GE HealthCare Recent Development Table 70. Bracco Diagnostic Company Information Table 71. Bracco Diagnostic Business Overview Table 72. Bracco Diagnostic Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio Table 74. Bracco Diagnostic Recent Development Table 75. Guerbet Company Information Table 76. Guerbet Business Overview Table 77. Guerbet Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Guerbet Diagnostic Imaging Agent Product Portfolio Table 79. Guerbet Recent Development Table 80. Abx Advanced Biochemical Company Information Table 81. Abx Advanced Biochemical Business Overview Table 82. Abx Advanced Biochemical Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio Table 84. Abx Advanced Biochemical Recent Development Table 85. Bayer AG Company Information Table 86. Bayer AG Business Overview Table 87. Bayer AG Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bayer AG Diagnostic Imaging Agent Product Portfolio Table 89. Bayer AG Recent Development Table 90. Blue Earth Diagnostics Company Information Table 91. Blue Earth Diagnostics Business Overview Table 92. Blue Earth Diagnostics Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio Table 94. Blue Earth Diagnostics Recent Development Table 95. Cardinal Health Company Information Table 96. Cardinal Health Business Overview Table 97. Cardinal Health Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Cardinal Health Diagnostic Imaging Agent Product Portfolio Table 99. Cardinal Health Recent Development Table 100. Eli Lilly and Company Company Information Table 101. Eli Lilly and Company Business Overview Table 102. Eli Lilly and Company Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio Table 104. Eli Lilly and Company Recent Development Table 105. Lantheus Company Information Table 106. Lantheus Business Overview Table 107. Lantheus Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Lantheus Diagnostic Imaging Agent Product Portfolio Table 109. Lantheus Recent Development Table 110. Mallinckrodt Company Information Table 111. Mallinckrodt Business Overview Table 112. Mallinckrodt Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Mallinckrodt Diagnostic Imaging Agent Product Portfolio Table 114. Mallinckrodt Recent Development Table 115. Navidea Company Information Table 116. Navidea Business Overview Table 117. Navidea Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Navidea Diagnostic Imaging Agent Product Portfolio Table 119. Navidea Recent Development Table 120. Yantai Dongcheng Company Information Table 121. Yantai Dongcheng Business Overview Table 122. Yantai Dongcheng Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio Table 124. Yantai Dongcheng Recent Development Table 125. Foshan Rui Diao Pharmaceutical Company Information Table 126. Foshan Rui Diao Pharmaceutical Business Overview Table 127. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio Table 129. Foshan Rui Diao Pharmaceutical Recent Development Table 130. Jubilant Pharma Limited Company Information Table 131. Jubilant Pharma Limited Business Overview Table 132. Jubilant Pharma Limited Diagnostic Imaging Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio Table 134. Jubilant Pharma Limited Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Diagnostic Imaging Agent Distributors List Table 138. Diagnostic Imaging Agent Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Diagnostic Imaging Agent Product Image Figure 2. Global Diagnostic Imaging Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Imaging Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Imaging Agent Sales (2021-2032) & (K Units) Figure 5. Global Diagnostic Imaging Agent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Diagnostic Imaging Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Conjugated Imaging Agent Image Figure 9. Metabolic Imaging Agent Image Figure 10. Blood Flow and Blood Volume Imaging Agents Image Figure 11. Global Diagnostic Imaging Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Diagnostic Imaging Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2032) Figure 14. Global Diagnostic Imaging Agent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Diagnostic Imaging Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2032) Figure 17. Neurological Disease Image Figure 18. Gastrointestinal Disease Image Figure 19. Heart Disease Image Figure 20. Tumor Image Figure 21. Global Diagnostic Imaging Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Diagnostic Imaging Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2032) Figure 24. Global Diagnostic Imaging Agent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Diagnostic Imaging Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2032) Figure 27. North America Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Diagnostic Imaging Agent Sales Market Share by Country (2021-2032) Figure 29. U.S. Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Diagnostic Imaging Agent Sales Market Share by Country (2021-2032) Figure 34. Germany Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Diagnostic Imaging Agent Sales Market Share by Country (2021-2032) Figure 41. China Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Diagnostic Imaging Agent Sales Market Share by Country (2021-2032) Figure 49. Brazil Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Diagnostic Imaging Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Diagnostic Imaging Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Diagnostic Imaging Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Figure 60. North America Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Figure 62. Europe Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Diagnostic Imaging Agent Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Diagnostic Imaging Agent Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Diagnostic Imaging Agent Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Conjugated Imaging Agent
  • Metabolic Imaging Agent
  • Blood Flow and Blood Volume Imaging Agents
Applications
  • Neurological Disease
  • Gastrointestinal Disease
  • Heart Disease
  • Tumor
Companies covered
  • GE HealthCare
  • Bracco Diagnostic
  • Guerbet
  • Abx Advanced Biochemical
  • Bayer AG
  • Blue Earth Diagnostics
  • Cardinal Health
  • Eli Lilly and Company
  • Lantheus
  • Mallinckrodt
  • Navidea
  • Yantai Dongcheng
  • Foshan Rui Diao Pharmaceutical
  • Jubilant Pharma Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diagnostic Imaging Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diagnostic Imaging Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Diagnostic Imaging Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Diagnostic Imaging Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Diagnostic Imaging Agent Market Dynamics
  1. 2.1 Diagnostic Imaging Agent Industry Trends
  2. 2.2 Diagnostic Imaging Agent Industry Drivers
  3. 2.3 Diagnostic Imaging Agent Industry Opportunities and Challenges
  4. 2.4 Diagnostic Imaging Agent Industry Restraints
3 Diagnostic Imaging Agent Market by Manufacturers
  1. 3.1 Global Diagnostic Imaging Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Diagnostic Imaging Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Diagnostic Imaging Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Diagnostic Imaging Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diagnostic Imaging Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Diagnostic Imaging Agent Manufacturers, Product Type & Application
  7. 3.7 Global Diagnostic Imaging Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diagnostic Imaging Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diagnostic Imaging Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diagnostic Imaging Agent Tier 1, Tier 2, and Tier 3
4 Diagnostic Imaging Agent Market by Type
  1. 4.1 Diagnostic Imaging Agent Type Introduction
  2. 4.1.1 Conjugated Imaging Agent
  3. 4.1.2 Metabolic Imaging Agent
  4. 4.1.3 Blood Flow and Blood Volume Imaging Agents
  5. 4.2 Global Diagnostic Imaging Agent Sales by Type
  6. 4.2.1 Global Diagnostic Imaging Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diagnostic Imaging Agent Sales by Type (2021-2032)
  8. 4.2.3 Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2032)
  9. 4.3 Global Diagnostic Imaging Agent Revenue by Type
  10. 4.3.1 Global Diagnostic Imaging Agent Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Diagnostic Imaging Agent Revenue by Type (2021-2032)
  12. 4.3.3 Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2032)
5 Diagnostic Imaging Agent Market by Application
  1. 5.1 Diagnostic Imaging Agent Application Introduction
  2. 5.1.1 Neurological Disease
  3. 5.1.2 Gastrointestinal Disease
  4. 5.1.3 Heart Disease
  5. 5.1.4 Tumor
  6. 5.2 Global Diagnostic Imaging Agent Sales by Application
  7. 5.2.1 Global Diagnostic Imaging Agent Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Diagnostic Imaging Agent Sales by Application (2021-2032)
  9. 5.2.3 Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2032)
  10. 5.3 Global Diagnostic Imaging Agent Revenue by Application
  11. 5.3.1 Global Diagnostic Imaging Agent Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Diagnostic Imaging Agent Revenue by Application (2021-2032)
  13. 5.3.3 Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2032)
6 Global Diagnostic Imaging Agent Sales by Region
  1. 6.1 Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diagnostic Imaging Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Diagnostic Imaging Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Diagnostic Imaging Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Diagnostic Imaging Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Diagnostic Imaging Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Diagnostic Imaging Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Diagnostic Imaging Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Diagnostic Imaging Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Diagnostic Imaging Agent Revenue by Region
  1. 7.1 Global Diagnostic Imaging Agent Revenue by Region
  2. 7.1.1 Global Diagnostic Imaging Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Diagnostic Imaging Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Diagnostic Imaging Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Diagnostic Imaging Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Diagnostic Imaging Agent Revenue (2021-2032)
  8. 7.2.2 North America Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Diagnostic Imaging Agent Revenue (2021-2032)
  11. 7.3.2 Europe Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Diagnostic Imaging Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Diagnostic Imaging Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Diagnostic Imaging Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GE HealthCare
  2. 8.1.1 GE HealthCare Company Information
  3. 8.1.2 GE HealthCare Business Overview
  4. 8.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
  6. 8.1.5 GE HealthCare Recent Developments
  7. 8.2 Bracco Diagnostic
  8. 8.2.1 Bracco Diagnostic Company Information
  9. 8.2.2 Bracco Diagnostic Business Overview
  10. 8.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
  12. 8.2.5 Bracco Diagnostic Recent Developments
  13. 8.3 Guerbet
  14. 8.3.1 Guerbet Company Information
  15. 8.3.2 Guerbet Business Overview
  16. 8.3.3 Guerbet Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
  18. 8.3.5 Guerbet Recent Developments
  19. 8.4 Abx Advanced Biochemical
  20. 8.4.1 Abx Advanced Biochemical Company Information
  21. 8.4.2 Abx Advanced Biochemical Business Overview
  22. 8.4.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
  24. 8.4.5 Abx Advanced Biochemical Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Blue Earth Diagnostics
  32. 8.6.1 Blue Earth Diagnostics Company Information
  33. 8.6.2 Blue Earth Diagnostics Business Overview
  34. 8.6.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
  36. 8.6.5 Blue Earth Diagnostics Recent Developments
  37. 8.7 Cardinal Health
  38. 8.7.1 Cardinal Health Company Information
  39. 8.7.2 Cardinal Health Business Overview
  40. 8.7.3 Cardinal Health Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
  42. 8.7.5 Cardinal Health Recent Developments
  43. 8.8 Eli Lilly and Company
  44. 8.8.1 Eli Lilly and Company Company Information
  45. 8.8.2 Eli Lilly and Company Business Overview
  46. 8.8.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
  48. 8.8.5 Eli Lilly and Company Recent Developments
  49. 8.9 Lantheus
  50. 8.9.1 Lantheus Company Information
  51. 8.9.2 Lantheus Business Overview
  52. 8.9.3 Lantheus Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lantheus Diagnostic Imaging Agent Product Portfolio
  54. 8.9.5 Lantheus Recent Developments
  55. 8.10 Mallinckrodt
  56. 8.10.1 Mallinckrodt Company Information
  57. 8.10.2 Mallinckrodt Business Overview
  58. 8.10.3 Mallinckrodt Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
  60. 8.10.5 Mallinckrodt Recent Developments
  61. 8.11 Navidea
  62. 8.11.1 Navidea Company Information
  63. 8.11.2 Navidea Business Overview
  64. 8.11.3 Navidea Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Navidea Diagnostic Imaging Agent Product Portfolio
  66. 8.11.5 Navidea Recent Developments
  67. 8.12 Yantai Dongcheng
  68. 8.12.1 Yantai Dongcheng Company Information
  69. 8.12.2 Yantai Dongcheng Business Overview
  70. 8.12.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
  72. 8.12.5 Yantai Dongcheng Recent Developments
  73. 8.13 Foshan Rui Diao Pharmaceutical
  74. 8.13.1 Foshan Rui Diao Pharmaceutical Company Information
  75. 8.13.2 Foshan Rui Diao Pharmaceutical Business Overview
  76. 8.13.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
  78. 8.13.5 Foshan Rui Diao Pharmaceutical Recent Developments
  79. 8.14 Jubilant Pharma Limited
  80. 8.14.1 Jubilant Pharma Limited Company Information
  81. 8.14.2 Jubilant Pharma Limited Business Overview
  82. 8.14.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
  84. 8.14.5 Jubilant Pharma Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diagnostic Imaging Agent Value Chain Analysis
  2. 9.1.1 Diagnostic Imaging Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diagnostic Imaging Agent Production Mode & Process
  6. 9.2 Diagnostic Imaging Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diagnostic Imaging Agent Distributors
  9. 9.2.3 Diagnostic Imaging Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst